Tirzepatide 20mg

Tirzepatide, also known as the active ingredient in Mounjaro, is a novel dual GIP and GLP-1 receptor agonist peptide that has attracted significant attention within the scientific research community. Its unique mechanism of action targets both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, making it a valuable compound for studies investigating metabolic processes, glucose regulation, appetite signalling, and body weight management.

Researchers continue to explore Tirzepatide's potential effects on insulin sensitivity, energy balance, and metabolic health through controlled laboratory investigations. Manufactured to high purity standards, Tirzepatide is intended strictly for laboratory research and analytical purposes.

For research use only. Not intended for human consumption, therapeutic use, or diagnostic applications.